Millie
your market intelligence analyst
Search Results
Edit Save
1,692 results
IFM to launch IFM Quattro, along with new incubator, IFM Discovery, and up to two additional subsidiaries focused on select targets of the innate immune system. Financing is led by new investor Omega Funds, with participation from existing investors Atla...
AN2's Series A focused on advancing novel treatments for infectious diseases of global significance. AN2 grants license to Brii Biosciences for study of the lead antibacterial program in greater China. MENLO PARK, Calif., Nov. 21, 2019 -- (Healthcare S... Biopharmaceuticals, Venture Capital AN2 Therapeutics, Brii Biosciences.

Personal Care

Household Products

Business Issues

Trends

Companies - Public

Companies - Venture Funded

Information Technologies

Regions

Job Titles